Connect with us

Business Partnerships

Privateer Holdings Agrees on Tilray Shares Extension Over Next Two Years

Published

on

Privateer Holdings Agrees on Tilray Shares Extension Over Next Two Years
  • Privateer Holdings was responsible for the Series A funding round for Tilray in early 2018.
  • The company also has three other subsidiaries.

Privateer Holdings incubated and financings Tilray Inc when it was first established in 2018. Before it closed a Series A funding round, Tilray was one of their wholly owned operating subsidiaries. Now, reports from Benzinga indicate that a new definitive agreement has been signed, extending a current lock-up on the Tilray shares. In doing so, they provide 77% of the shares to the equity holders from Privateer over the next two years.

Unrelated to Tilray, Privateer chose to distribute ownership involving three other subsidiaries to their stockholder. This decision led Privateer to be left with no material assets, apart from the Tilray share, of which it holds 75 million.

Mark Castaneda, the CFO of Tilray, stated:

“We appreciate the long-term confidence that Privateer has in the Tilray business and we look forward to having their investors as part of our stockholder base.” He added that the transaction involving Privateer opens the door for more control and more flexibility. However, they are still able to properly “manage our public float.”

Earlier today, the shares of Tilray were down by over 4%, priced at $30.75. Over the course of the last year, the stock has seen a high of $300 and a low of $25.15.

Stephen resides in Yorkshire, UK and is in his mid-fifties. Aside from a wide range of occupations, he was a National Health Service manager and psychiatric registered nurse before becoming a full time freelance writer. As a dedicated lifelong learner and rigid researcher, Stephen is keen to be one of our best contributors for year to come in the hemp and CBD industries.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.